The Clinical Development Team at Adaptimmune is responsible for designing, implementing, and overseeing clinical trials to evaluate the safety and efficacy of novel immunotherapies. This multidisciplinary team collaborates on various aspects of clinical research, including trial design, biomarker analysis, clinical safety, and regulatory compliance, to ensure that the development of innovative cancer treatments is conducted efficiently and ethically. Their ultimate goal is to bring breakthrough therapies to patients through rigorous clinical evaluation.
Amy Sauer
Director, Clinical Scientist
Ciara Higgins
Senior Director, Clinical Deve...
Daniel Campbell
Director, Clinical Scientist
Emily Page
Clinical Trial Support Special...
Erin van Winkle
Senior Director, Clinical Deve...
Fran Brophy
Senior Director, Clinical Scie...
Lilliam Ribeiro
Director For Clinical Safety A...
Molly-Ann McNickle
Manager, Clinical Scientist
Olga O.
Clinical Samples Manager - Tra...
Tianjiao Wang
Associate Director, Clinical B...
View all